The Fascinating, infuriating story of how we built the world's most expensive, least equitable, health care system -- and what we can do to fix it. -- cover.

In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical...

"While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public...

"The vast majority of American experiences with drugs and addiction in America take place in white markets, where the legal and medically approved and prescribed drugs change hands. Historian David Herzberg recovers the rich but largely forgotten history of these white markets, restoring some of the nation's most widely prescribed medicines to their proper role as central to the history of addiction and drug policy. White Market Drugs is the first...